ATORVASTATIN AUROVITAS

80MG TBL FLM 30 II

SÚKL code 0226055
Name of the product ATORVASTATIN AUROVITAS
_MA_MEDICATION_DETAIL_INFO_MED_NAME i ATORVASTATIN AUROVITAS
Supplement 80MG TBL FLM 30 II
Strenght 80MG
Pharmaceutical form Film-coated tablet
Package 30 II
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance ATORVASTATIN CALCIUM TRIHYDRATE (ATORVASTATINUM CALCICUM TRIHYDRICUM)
ATC group C10AA05
ATC group name ATORVASTATIN

Marketing authorisation information

Registration Number 31/ 443/16-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 04. 2020
MA Holder Aurovitas Pharma Polska Sp. z o.o., Warszawa
MA Holder country POLSKO
Actual MA holder Aurovitas, spol. s r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list